It has been observed that M1-derived exosomes and nanovesicles derived from those exosomes can polarize M2 macrophages to M1 type and trigger CD8+ T cell response, thereby reducing tumor progression (Choo et al., 2018). Here, CD8A is linked to neoplasm.